Search research articles
Contact Us
Filters
Showing results (141-150 of 513) with videos related to
Page
of 52
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 30, 2009
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis
Corey A Siegel, Sadie M Marden, Sarah M Persing, et al.
American Journal of Clinical Pathology
|
April 22, 2017
Achieving High Reliability in Histology: An Improvement Series to Reduce Errors
Yael K Heher, Yigu Chen, Sergey Pyatibrat, et al.
The New England Journal of Medicine
|
October 29, 2025
Case 31-2025: A 56-Year-Old Man with Left Lower Abdominal Pain and Anemia
Bruce E Sands, Anuradha S Shenoy-Bhangle, Jacob E Lemieux, et al.
The New Zealand Medical Journal
|
July 1, 1972
XXXXY syndrome with mosaicism: case report
R J Gardner, V E Sands, A M Veale, et al.
Gut
|
June 4, 2024
Acute severe ulcerative colitis trials: the past, the present and the future
Sailish Honap, Vipul Jairath, Bruce E Sands, et al.
Journal of Managed Care Pharmacy : JMCP
|
September 28, 2010
Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management
F Reed Johnson, Brett Hauber, Semra Özdemir, et al.
Inflammatory Bowel Diseases
|
October 29, 2005
State of the art: IBD therapy and clinical trials in IBD
Kim L Isaacs, James D Lewis, William J Sandborn, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
October 2, 2008
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
F Reed Johnson, Semra Ozdemir, Carol Mansfield, et al.
Alimentary Pharmacology & Therapeutics
|
July 16, 2025
Clinical Trial: Association Between Early Disease Clearance and Long-Term Outcomes-4-Year Results From the Phase 3 UNIFI Study of Ustekinumab in Ulcerative Colitis
Silvio Danese, Rupert W Leong, Bruce E Sands, et al.
Journal of Clinical Gastroenterology
|
April 6, 2012
A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States
Andrew Tinsley, Steven Naymagon, Arvind J Trindade, et al.
Page
of 52
Search research articles
Search
Showing results (141-150 of 513) with videos related to
Sort By:
Page
of 52
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 30, 2009
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis
Corey A Siegel, Sadie M Marden, Sarah M Persing, et al.
American Journal of Clinical Pathology
|
April 22, 2017
Achieving High Reliability in Histology: An Improvement Series to Reduce Errors
Yael K Heher, Yigu Chen, Sergey Pyatibrat, et al.
The New England Journal of Medicine
|
October 29, 2025
Case 31-2025: A 56-Year-Old Man with Left Lower Abdominal Pain and Anemia
Bruce E Sands, Anuradha S Shenoy-Bhangle, Jacob E Lemieux, et al.
The New Zealand Medical Journal
|
July 1, 1972
XXXXY syndrome with mosaicism: case report
R J Gardner, V E Sands, A M Veale, et al.
Gut
|
June 4, 2024
Acute severe ulcerative colitis trials: the past, the present and the future
Sailish Honap, Vipul Jairath, Bruce E Sands, et al.
Journal of Managed Care Pharmacy : JMCP
|
September 28, 2010
Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management
F Reed Johnson, Brett Hauber, Semra Özdemir, et al.
Inflammatory Bowel Diseases
|
October 29, 2005
State of the art: IBD therapy and clinical trials in IBD
Kim L Isaacs, James D Lewis, William J Sandborn, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
October 2, 2008
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
F Reed Johnson, Semra Ozdemir, Carol Mansfield, et al.
Alimentary Pharmacology & Therapeutics
|
July 16, 2025
Clinical Trial: Association Between Early Disease Clearance and Long-Term Outcomes-4-Year Results From the Phase 3 UNIFI Study of Ustekinumab in Ulcerative Colitis
Silvio Danese, Rupert W Leong, Bruce E Sands, et al.
Journal of Clinical Gastroenterology
|
April 6, 2012
A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States
Andrew Tinsley, Steven Naymagon, Arvind J Trindade, et al.
Page
of 52